Drug Shortage Report for FLUMAZENIL INJECTION
| Report ID | 148857 |
| Drug Identification Number | 02266342 |
| Brand name | FLUMAZENIL INJECTION |
| Common or Proper name | Flumazenil Injection 0.1 mg/mL MD Vial 5 mL |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | FLUMAZENIL |
| Strength(s) | 0.1MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 5 mL |
| ATC code | V03AB |
| ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2021-12-01 |
| Actual start date | 2021-12-01 |
| Estimated end date | 2022-02-15 |
| Actual end date | 2022-02-16 |
| Shortage status | Resolved |
| Updated date | 2022-02-17 |
| Company comments | Fresenius Kabi Canada regrets to advise that due to further production delays we will be extending the backorder on our Flumazenil Injection 0.1 mg/mL MD Vial 5 mL until February 15, 2022. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v16 | 2022-02-17 | English | Compare |
| v15 | 2022-02-14 | French | Compare |
| v14 | 2022-02-14 | English | Compare |
| v13 | 2022-01-24 | French | Compare |
| v12 | 2022-01-24 | English | Compare |
| v11 | 2022-01-11 | French | Compare |
| v10 | 2022-01-11 | English | Compare |
| v9 | 2021-12-16 | French | Compare |
| v8 | 2021-12-16 | English | Compare |
| v7 | 2021-12-09 | French | Compare |
| v6 | 2021-12-09 | English | Compare |
| v5 | 2021-12-02 | English | Compare |
| v4 | 2021-11-30 | French | Compare |
| v3 | 2021-11-30 | English | Compare |
| v2 | 2021-11-04 | French | Compare |
| v1 | 2021-11-04 | English | Compare |
Showing 1 to 16 of 16